“Plaza Suite” continues through Nov. 29 at Long Beach Playhouse, 5021 E. Anaheim St., with shows Fridays and Saturdays at 8 p ...

Bringing media buying in-house is “chaotic and disruptive” – but totally worth it, according to Glenniss Richards, Bayer’s senior director of digital media. Richards spearheaded the in-housing effort ...

Bayer Leverkusen Chief Executive Officer Fernando Carro has called for an international salary cap for football players, warning that the English Premier League’s financial dominance could undermine ...

ST. PAUL, Minn., Sept. 10 (UPI) --German pharma giant Bayer this week published the full results of a major clinical study demonstrating the long-term safety and efficacy of its hot flash drug ...

Ann Marie (Erickson) Bayer, age 87, passed away on Sunday, August 31, 2025, at Parkside Retirement Community in DeForest, WI. She was born on October 23, 1937, to Roy and Vivian (Wang) Erickson in ...

Erik Ten Hag as said he “never” got the trust he deserved with Bayer Leverkusen after his “unprecedented” sacking on Monday. The former Manchester United manager was sacked by the Bundesliga side ...

Erik ten Hag has been sacked by Bayer Leverkusen after just three competitive games at the helm, the club have confirmed. Ten Hag only joined Leverkusen this summer as a replacement for new Real ...

Bayer announced July 30 that it has submitted applications in four major agricultural markets—the European Union, Brazil, Canada, and the United States—for a new herbicide with a new mode of action, ...

Evaluating the effectiveness of a creative ad remains a critical, ongoing consideration for health brands. Improving content quality is more than just an exercise in creative pride, there are ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Bayer AG has reached agreements ...

Bayer BAYN-0.72%decrease; red down pointing triangle said it would commercialize and complete research into a new potential cancer drug developed by U.S. biotech company Kumquat Biosciences. Under the ...

Bayer has teamed up with Kumquat Biosciences for a juicy opportunity, committing up to $1.3 billion for the global license to a KRAS G12D inhibitor that is on the cusp of the clinic. Kumquat, which ...